Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:16 pm Purchase | 2023-12-31 | 13G | Sadot Group Inc. SDOT | Armistice Capital, LLC | 60,742 9.990% | 60,742![]() (New Position) | Filing History |
| 2024-11-14 5:16 pm Purchase | 2024-09-30 | 13G | Presidio Property Trust, Inc. SQFT | Armistice Capital, LLC | 161,283 9.990% | 15,556![]() (+10.68%) | Filing History |
| 2024-11-14 5:15 pm Purchase | 2024-09-30 | 13G | Mural Oncology plc MURA | Armistice Capital, LLC | 1,700,000 9.980% | 42,000![]() (+2.53%) | Filing History |
| 2024-11-14 5:15 pm Purchase | 2024-09-30 | 13G | Staffing 360 Solutions, Inc. STAF | Armistice Capital, LLC | 105,610 9.990% | 105,610![]() (New Position) | Filing History |
| 2024-11-14 5:14 pm Unchanged | 2024-09-30 | 13G | Momentus Inc. MNTS | Armistice Capital, LLC | 202,476 9.990% | 0 (Unchanged) | Filing History |
| 2024-11-14 5:14 pm Purchase | 2024-09-30 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Armistice Capital, LLC | 5,096,000 9.250% | 446,000![]() (+9.59%) | Filing History |
| 2024-11-14 5:14 pm Purchase | 2024-09-30 | 13G | Momentus Inc. MNTS | Armistice Capital, LLC | 202,476 9.990% | 167,334![]() (+476.15%) | Filing History |
| 2024-11-14 5:13 pm Purchase | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | Armistice Capital, LLC | 7,648,000 10.000% | 264,000![]() (+3.58%) | Filing History |
| 2024-11-14 5:13 pm Purchase | 2024-09-30 | 13G | MacroGenics, Inc. MGNX | Armistice Capital, LLC | 6,258,000 9.980% | 1,686,000![]() (+36.88%) | Filing History |
| 2024-11-14 5:12 pm Purchase | 2024-09-30 | 13G | Catheter Precision, Inc. VTAK | Armistice Capital, LLC | 5,565 9.990% | 5,565![]() (New Position) | Filing History |
| 2024-11-14 5:12 pm Purchase | 2024-09-30 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 5,200,000 9.540% | 964,000![]() (+22.76%) | Filing History |
| 2024-11-14 5:12 pm Purchase | 2024-09-30 | 13G | Moleculin Biotech, Inc. MBRX | Armistice Capital, LLC | 12,040 9.990% | 12,040![]() (New Position) | Filing History |
| 2024-11-14 5:10 pm Sale | 2024-09-30 | 13G | GeoVax Labs, Inc. GOVX | Armistice Capital, LLC | 946,137 9.990% | -2,164,932![]() (-69.59%) | Filing History |
| 2024-11-14 5:08 pm Purchase | 2024-09-30 | 13G | Eyenovia, Inc. EYEN | Armistice Capital, LLC | 107,500 9.950% | 52,775![]() (+96.44%) | Filing History |
| 2024-11-14 5:07 pm Purchase | 2024-09-30 | 13G | Dermata Therapeutics, Inc. DRMA | Armistice Capital, LLC | 18,621 9.990% | 18,621![]() (New Position) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Armistice Capital, LLC | 1,313,348 9.990% | 234,889![]() (+21.78%) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | BIO-key International, Inc. BKYI | Armistice Capital, LLC | 250,000 8.950% | 128,506![]() (+105.77%) | Filing History |
| 2024-11-14 5:03 pm Purchase | 2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS | Armistice Capital, LLC | 319,756 9.990% | 319,756![]() (New Position) | Filing History |
| 2024-11-14 5:01 pm Purchase | 2024-09-30 | 13G | Worksport Ltd. WKSP | Armistice Capital, LLC | 309,777 9.990% | 103,188![]() (+49.95%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | T Stamp Inc. IDAI | Armistice Capital, LLC | 134,886 9.990% | 72,406![]() (+115.89%) | Filing History |

